Summary of Bill S 760: Insurance Coverage for Epinephrine Auto-Injectors

Bill Overview

• Bill Number: S 760
• Title: Relates to requiring insurance coverage for epinephrine auto-injectors
• Status: Signed into law (Chap. 81)
• Introduced: January 8, 2025

Purpose and Intent

The primary purpose of Bill S 760 is to mandate that health insurance plans provide coverage for epinephrine auto-injectors. This legislation aims to improve access to life-saving medication for individuals at risk of severe allergic reactions (anaphylaxis), thereby enhancing public health and safety.

Key Provisions

• Insurance Coverage Requirement: The bill requires all health insurance policies to cover epinephrine auto-injectors without imposing excessive cost-sharing measures, such as high deductibles or copayments.
• Accessibility: The legislation ensures that individuals with allergies can obtain these critical devices without financial barriers, promoting timely treatment in emergency situations.

Affected Parties

• Individuals with Allergies: The primary beneficiaries of this bill are individuals who suffer from severe allergies and require epinephrine auto-injectors for emergency treatment.
• Health Insurance Providers: Insurance companies will need to adjust their policies to comply with the new coverage requirements.
• Healthcare Providers: Physicians and healthcare professionals will have clearer guidelines regarding the prescription and coverage of epinephrine auto-injectors.

Legislative Timeline

• January 8, 2025: Bill introduced and referred to rules.
• February 4, 2025: Passed in the Senate and delivered to the Assembly.
• February 5, 2025: Substituted for companion bill A 2443, passed in the Assembly, and returned to the Senate.
• February 12, 2025: Delivered to the Governor.
• February 14, 2025: Signed into law as Chap. 81.

Conclusion

Bill S 760 represents a significant step towards ensuring that individuals at risk of anaphylaxis have access to necessary medical treatment without financial hardship. By mandating insurance coverage for epinephrine auto-injectors, the legislation aims to save lives and improve health outcomes for those affected by severe allergies.